JP2018535952A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535952A5 JP2018535952A5 JP2018519423A JP2018519423A JP2018535952A5 JP 2018535952 A5 JP2018535952 A5 JP 2018535952A5 JP 2018519423 A JP2018519423 A JP 2018519423A JP 2018519423 A JP2018519423 A JP 2018519423A JP 2018535952 A5 JP2018535952 A5 JP 2018535952A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- lipid
- popc
- distearoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1518172.0A GB201518172D0 (en) | 2015-10-14 | 2015-10-14 | Colloidal particles for use in medicine |
| GB1518172.0 | 2015-10-14 | ||
| PCT/EP2016/074759 WO2017064276A1 (en) | 2015-10-14 | 2016-10-14 | Colloidal particles for use in medicine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535952A JP2018535952A (ja) | 2018-12-06 |
| JP2018535952A5 true JP2018535952A5 (cg-RX-API-DMAC10.html) | 2019-12-26 |
| JP7160678B2 JP7160678B2 (ja) | 2022-10-25 |
Family
ID=55131025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519423A Expired - Fee Related JP7160678B2 (ja) | 2015-10-14 | 2016-10-14 | 医薬用コロイド粒子 |
Country Status (15)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122516130A (zh) * | 2019-11-07 | 2026-08-07 | 伊利诺伊大学评议会 | 治疗脓毒症、动脉粥样硬化、血栓形成、中风、心脏病发作和炎症的肽和方法 |
| GB202111758D0 (en) * | 2021-08-17 | 2021-09-29 | Cantab Biopharmaceuticals Patents Ltd | Modified colloidal particles for use in the treatment of haemophilia A |
| GB202111759D0 (en) * | 2021-08-17 | 2021-09-29 | Cantab Biopharmaceuticals Patents Ltd | Modified colloidal particles |
| GB202111757D0 (en) * | 2021-08-17 | 2021-09-29 | Cantab Biopharmaceuticals Patents Ltd | Modified colloidal particles for use in the treatment of haemophilia A |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| AU7384994A (en) | 1993-08-06 | 1995-02-28 | Opperbas Holding B.V. | A method for high loading of vesicles with biopolymeric substances |
| CA2329768C (en) | 1998-04-27 | 2008-06-10 | Opperbas Holding B.V. | Pharmaceutical composition comprising factor viii and neutral liposomes |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| PT1198490E (pt) | 1999-07-14 | 2006-06-30 | Alza Corp | Lipopolimeros neutros e composicoes liposomais que contem os mesmos |
| US20030232075A1 (en) * | 2002-05-06 | 2003-12-18 | University Of Minnesota, A Minnesota Corporation | Compositions for producing factor Xa |
| PT1633440E (pt) | 2003-04-15 | 2008-08-25 | Opperbas Holding Bv | Composição farmacêutica que compreende proteínas e/ou polipéptidos e partículas coloidais |
| BRPI0612843A2 (pt) | 2005-06-29 | 2010-11-30 | The Research Foundation Of State University Of New York | composição farmacêutica, métodos para fabricar a composição, e, uso de uma formulação |
| JP2012528846A (ja) | 2009-06-03 | 2012-11-15 | マヨ、ジョン、チャールズ | 深部組織の痛みを治療するための製剤 |
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| HK1200695A1 (en) | 2012-04-16 | 2015-08-14 | Cantab Biopharmaceuticals Patents Limited | Optimised subcutaneous therapeutic agents |
| ES2887254T3 (es) * | 2013-03-08 | 2021-12-22 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
-
2015
- 2015-10-14 GB GBGB1518172.0A patent/GB201518172D0/en not_active Ceased
-
2016
- 2016-10-14 CN CN201680073237.XA patent/CN108472246A/zh active Pending
- 2016-10-14 SG SG11201802956RA patent/SG11201802956RA/en unknown
- 2016-10-14 EP EP16781807.9A patent/EP3362039A1/en active Pending
- 2016-10-14 CA CA3036111A patent/CA3036111C/en active Active
- 2016-10-14 BR BR112018007399A patent/BR112018007399A2/pt not_active Application Discontinuation
- 2016-10-14 EA EA201890703A patent/EA201890703A1/ru unknown
- 2016-10-14 SG SG10202010711UA patent/SG10202010711UA/en unknown
- 2016-10-14 WO PCT/EP2016/074759 patent/WO2017064276A1/en not_active Ceased
- 2016-10-14 JP JP2018519423A patent/JP7160678B2/ja not_active Expired - Fee Related
- 2016-10-14 IL IL258567A patent/IL258567B2/en unknown
- 2016-10-14 KR KR1020187013254A patent/KR20180067616A/ko not_active Ceased
- 2016-10-14 US US15/768,381 patent/US20190192664A1/en not_active Abandoned
- 2016-10-14 HK HK18115899.0A patent/HK1256814A1/zh unknown
- 2016-10-14 AU AU2016336929A patent/AU2016336929B2/en not_active Ceased
- 2016-10-14 MX MX2018004445A patent/MX391574B/es unknown
-
2020
- 2020-05-26 US US16/883,338 patent/US20210093721A1/en not_active Abandoned
-
2024
- 2024-06-24 US US18/752,365 patent/US20250170244A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chang et al. | Liposomal dexamethasone–moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing | |
| JP2015527391A (ja) | ヒアルロン酸をベースとする薬物送達システム | |
| Ding et al. | Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system | |
| Zhu et al. | Supramolecular hydrogels from cisplatin-loaded block copolymer nanoparticles and α-cyclodextrins with a stepwise delivery property | |
| TWI556838B (zh) | 治療關節炎之方法 | |
| Stillman et al. | Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants | |
| JP5702734B2 (ja) | 局所投与に好適なイミダゾキノリン（アミン）及びその誘導体を含む医薬組成物 | |
| JP2020073617A (ja) | 免疫療法のための調節粒子 | |
| Wang et al. | Bisphosphonate‐decorated lipid nanoparticles designed as drug carriers for bone diseases | |
| Salzano et al. | Self-assembly nanoparticles for the delivery of bisphosphonates into tumors | |
| Zhao et al. | Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review | |
| Cetin et al. | Polymer‐and lipid‐based nanostructures serving wound healing applications: A review | |
| Karami et al. | Synthesis and characterization of a novel hydrogel based on carboxymethyl chitosan/sodium alginate with the ability to release simvastatin for chronic wound healing | |
| CN101829046B (zh) | 一种两亲性嵌段聚合物胶束纳米载药系统及制备方法 | |
| AU2016211696B2 (en) | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces | |
| CN106237340B (zh) | 透明质酸纳米颗粒在制备治疗淋巴系统肿瘤的药物的用途 | |
| Abou-ElNour et al. | Microparticles-in-thermoresponsive/bioadhesive hydrogels as a novel integrated platform for effective intra-articular delivery of triamcinolone acetonide | |
| JP2008517878A5 (cg-RX-API-DMAC10.html) | ||
| JP2017507968A (ja) | 粘膜送達用のリポソーム組成物 | |
| Tao et al. | Liposomal stabilization using a sugar-based, PEGylated amphiphilic macromolecule | |
| Gao et al. | A rod bacterium-like magnetic polymer micelle for strongly enhancing selective accumulation and internalization of nanocarriers | |
| JP2017531659A5 (cg-RX-API-DMAC10.html) | ||
| HRP20230985T1 (hr) | Farmaceutske formulacije pegiliranih liposoma i faktora koagulacije krvi | |
| Benedini et al. | Nanodevices for facing new challenges of medical treatments: Stimuli-responsive drug delivery systems | |
| JP2009161460A (ja) | 乳化性製剤 |